Literature DB >> 870431

Effect of protein A on staphylococcal opsonization.

P K Peterson, J Verhoef, L D Sabath, P G Quie.   

Abstract

To study the effect of wall protein A on bacterial opsonization, phagocytosis of 10 strains of Staphylococcus aureus with high and low protein A contents was measured. Those strains that contained the highest concentrations of protein A were phagocytized by human neutrophils at a slower rate than strains with little or no protein A when normal human serum and purified immunoglobulin G (IgG) were used as opsonic sources. When IgG-deficient serum was used as an source, however, protein A-rich strains were phagocytized more rapidly than protein A-deficient strains. Extracellular (purified) protein A decrease the opsonic activity of all sera tested including IgG-deficient serum. It is proposed that when IgG is not present in the opsonic medium, cell wall protein A is capable of activating complement at the bacterial surface and thereby opsonization is promoted.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870431      PMCID: PMC421436          DOI: 10.1128/iai.15.3.760-764.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Effects of staphylococcal protein A on heat labile opsonins.

Authors:  A Forsgren; P G Quie
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

2.  "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin.

Authors:  A Forsgren; J Sjöquist
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

3.  Protein A from Staphylococcus aureus: the biological significance of its reaction with IgG.

Authors:  A Forsgren; K Nordström
Journal:  Ann N Y Acad Sci       Date:  1974-07-31       Impact factor: 5.691

4.  Antiphagocytic effects of staphylococcal protein A.

Authors:  J H Dossett; G Kronvall; R C Williams; P G Quie
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

5.  Sensitized sheep red cells as a reactant for Staphylococcus aureus protein A. Methodology and epidemiology with special reference to weakly reacting methicillin-resistant strains.

Authors:  S Winblad; C Ericson
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-02

6.  Consumption of human complement components by complexes of IgG with protein A of Staphylococcus aureus.

Authors:  G Stålenheim; O Götze; N R Cooper; J Sjöquist; H J Müller-Eberhard
Journal:  Immunochemistry       Date:  1973-08

7.  Protein A isolated from Staphylococcus aureus after digestion with lysostaphin.

Authors:  J Sjöquist; B Meloun; H Hjelm
Journal:  Eur J Biochem       Date:  1972-09-25

8.  Variation in staphylococcal protein A reactivity with gamma G-globulins of different species.

Authors:  I Lind; I Live; B Mansa
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1970

9.  Protein A mutants of Staphylococcus aureus.

Authors:  A Forsgren; K Nordström; L Philipson; J Sjöquist
Journal:  J Bacteriol       Date:  1971-07       Impact factor: 3.490

10.  Protein A from Staphylococcus aureus. 8. Production of protein A by bacterial and L-forms of S. aureus.

Authors:  A Forsgren
Journal:  Acta Pathol Microbiol Scand       Date:  1969
View more
  62 in total

1.  Flow cytometric assay for quantifying opsonophagocytosis and killing of Staphylococcus aureus by peripheral blood leukocytes.

Authors:  E Martin; S Bhakdi
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

Review 2.  Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.

Authors:  D P Greenberg; H R Stutman
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

3.  Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A.

Authors:  E R Wann; A P Fehringer; Y V Ezepchuk; P M Schlievert; P Bina; R F Reiser; M M Höök; D Y Leung
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate.

Authors:  K E Veldkamp; H C Heezius; J Verhoef; J A van Strijp; K P van Kessel
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Staphylococcus aureus in chronic and recurrent infections.

Authors:  L Slobodníková; D Kotulová; I Zahradníková
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

6.  Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci.

Authors:  E Whitnack; E H Beachey
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

7.  Release of protein A from the cell wall of Staphylococcus aureus.

Authors:  Samuel Becker; Matthew B Frankel; Olaf Schneewind; Dominique Missiakas
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

8.  Complement activation in Staphylococcus aureus bacteraemia.

Authors:  A F Hallett; R Cooper
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

9.  Virulence of Staphylococcus aureus mutants altered in type 5 capsule production.

Authors:  A Albus; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.

Authors:  C P Timmerman; E Mattsson; L Martinez-Martinez; L De Graaf; J A Van Strijp; H A Verbrugh; J Verhoef; A Fleer
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.